Insights into the effects of the endocannabinoid system in cancer: a review

No abstract is available for this paper.

• Publication year

  2018

• Venue

  British Journal of Pharmacology

• Publication date

  2018-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/bph.14331PMID 29663308PMCID PMC6003657
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rimonabant Kills Colon Cancer Stem Cells without Inducing Toxicity in Normal Colon Organoids

  2018cited by this paper
• G protein‐coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1

  2018cited by this paper
• Insights into the effects of the endocannabinoid system in cancer: a review

  2018cited by this paper
• THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein‐coupled receptors

  2017cited by this paper
• A Review of the Therapeutic Antitumor Potential of Cannabinoids

  2017cited by this paper
• Pharmacological inhibition of MAGL attenuates experimental colon carcinogenesis

  2017cited by this paper
• THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Other ion channels

  2017cited by this paper
• Endocannabinoids: A Promising Impact for Traumatic Brain Injury

  2017cited by this paper
• THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Catalytic receptors

  2017cited by this paper
• THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Voltage‐gated ion channels

  2017cited by this paper
• An Update on Non-CB1, Non-CB2 Cannabinoid Related G-Protein-Coupled Receptors

  2017influential reference
• Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting.

  2017cited by this paper
• The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY

  2017cited by this paper
• THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Transporters

  2017cited by this paper
• Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease

  2017cited by this paper
• Cannabinoid receptor ligand bias: implications in the central nervous system

  2017cited by this paper
• THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview

  2017cited by this paper
• Fatty acid amide hydrolase (FAAH) inhibitor PF-3845 reduces viability, migration and invasiveness of human colon adenocarcinoma Colo-205 cell line: an in vitro study.

  2017cited by this paper
• Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer

  2017cited by this paper
• THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes

  2017cited by this paper
• From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology.

  2016cited by this paper
• Curcumin as a Modulator of P-Glycoprotein in Cancer: Challenges and Perspectives

  2016influential reference
• Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance

  2016influential reference
• Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer

  2016cited by this paper
• Antitumorigenic targets of cannabinoids – current status and implications

  2016cited by this paper
• Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer

  2016cited by this paper
• The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease

  2016cited by this paper
• Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis

  2016influential reference
• Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas

  2016cited by this paper
• Regulation of multidrug resistance by microRNAs in anti-cancer therapy

  2016cited by this paper
• Comparing the effects of endogenous and synthetic cannabinoid receptor agonists on survival of gastric cancer cells.

  2016cited by this paper
• Cost-effectiveness analysis of whole-mount pathology processing for patients with early breast cancer undergoing breast conservation.

  2016cited by this paper
• Cannabinoids and autoimmune diseases: A systematic review.

  2016cited by this paper
• Anticancer mechanisms of cannabinoids.

  2016cited by this paper
• Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients’ survival

  2016influential reference
• Spontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system

  2016cited by this paper
• Anti-carcinogenic activity of anandamide on human glioma in vitro and in vivo

  2015cited by this paper
• Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells

  2015cited by this paper
• The antitumor action of cannabinoids on glioma tumorigenesis.

  2015cited by this paper
• The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis

  2015cited by this paper
• Endocannabinoid and ceramide levels are altered in patients with colorectal cancer.

  2015cited by this paper
• Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer.

  2015cited by this paper
• Proapoptotic effect of endocannabinoids in prostate cancer cells

  2015influential reference
• Cannabinoids receptor type 2, CB2, expression correlates with human colon cancer progression and predicts patient survival

  2015cited by this paper
• The influence of monoacylglycerol lipase inhibition upon the expression of epidermal growth factor receptor in human PC-3 prostate cancer cells

  2014cited by this paper
• Association of cannabinoid receptor expression with anandamide concentrations in endometrial cancer

  2014cited by this paper
• The Role of Monoacylglycerol Lipase (MAGL) in the Cancer Progress

  2014cited by this paper
• Anandamide inhibits breast tumor-induced angiogenesis

  2014influential reference
• Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling

  2014cited by this paper
• Targeting multiple cannabinoid anti‐tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer

  2014cited by this paper
• Cannabinoid receptor type 1 immunoreactivity and disease severity in human epithelial ovarian tumors.

  2014cited by this paper
• Receptor-dependent and receptor-independent endocannabinoid signaling: a therapeutic target for regulation of cancer growth.

  2013cited by this paper
• Expression and Functional Relevance of Cannabinoid Receptor 1 in Hodgkin Lymphoma

  2013influential reference
• Cannabidiol changes P-gp and BCRP expression in trophoblast cell lines

  2013influential reference
• The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas

  2013cited by this paper
• Association between Cannabinoid CB1 Receptor Expression and Akt Signalling in Prostate Cancer

  2013cited by this paper
• Expression of the cannabinoid type I receptor and prognosis following surgery in colorectal cancer

  2012cited by this paper
• Cannabinoid receptors: nomenclature and pharmacological principles.

  2012cited by this paper
• CB_2 and TRPV1 receptors mediate cannabinoid actions on MDR1 expression in multidrug resistant cells

  2012cited by this paper
• The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice.

  2012cited by this paper
• Alteration of endocannabinoid system in human gliomas

  2012influential reference
• Cannabidiol inhibits angiogenesis by multiple mechanisms

  2012cited by this paper
• The orphan receptor GPR 55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas

  2012cited by this paper
• The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation

  2011cited by this paper
• Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer.

  2011cited by this paper
• Antiproliferative mechanism of a cannabinoid agonist by cell cycle arrest in human gastric cancer cells

  2011cited by this paper
• High Tumour Cannabinoid CB1 Receptor Immunoreactivity Negatively Impacts Disease-Specific Survival in Stage II Microsatellite Stable Colorectal Cancer

  2011cited by this paper
• Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells.

  2011cited by this paper
• Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis.

  2011cited by this paper
• Endocannabinoid system in cardiovascular disorders - new pharmacotherapeutic opportunities

  2011cited by this paper
• The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK

  2011cited by this paper
• What is the natural ligand of GPR55?

  2011cited by this paper
• Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis.

  2011cited by this paper
• Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas.

  2010cited by this paper
• Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

  2010cited by this paper
• Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non–Small Cell Lung Cancer Growth and Metastasis

  2010cited by this paper
• The endogenous cannabinoid, anandamide, induces COX-2-dependent cell death in apoptosis-resistant colon cancer cells.

  2010cited by this paper
• Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2).

  2010influential reference
• THEMED ISSUE: CANNABINOIDS RESEARCH PAPER Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells

  2010cited by this paper
• Endocannabinoid‐like N‐arachidonoyl serine is a novel pro‐angiogenic mediator

  2010cited by this paper
• THEMED ISSUE: CANNABINOIDS RESEARCH PAPER A role for L-a-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells

  2010cited by this paper
• The levels of the endocannabinoid receptor CB2 and its ligand 2-arachidonoylglycerol are elevated in endometrial carcinoma.

  2010influential reference
• Fatty Acid Amide Hydrolase in Prostate Cancer: Association with Disease Severity and Outcome, CB1 Receptor Expression and Regulation by IL-4

  2010cited by this paper
• Multidrug resistance in breast cancer cells during epithelial-mesenchymal transition is modulated by breast cancer resistant protein.

  2010cited by this paper
• Effects of anandamide on polyamine levels and cell growth in human colon cancer cells.

  2010cited by this paper
• Pharmacological synergism between cannabinoids and paclitaxel in gastric cancer cell lines.

  2009cited by this paper
• Potentiation of Cannabinoid-Induced Cytotoxicity in Mantle Cell Lymphoma through Modulation of Ceramide Metabolism

  2009cited by this paper
• Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans.

  2009cited by this paper
• A high cannabinoid CB(1) receptor immunoreactivity is associated with disease severity and outcome in prostate cancer.

  2009cited by this paper
• Cannabinoid receptor-independent cytotoxic effects of cannabinoids in human colorectal carcinoma cells: synergism with 5-fluorouracil

  2009cited by this paper
• The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway.

  2008cited by this paper
• Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1).

  2008cited by this paper
• Cannabinoids in pancreatic cancer: Correlation with survival and pain

  2008influential reference
• Cannabinoid Receptor Activation Induces Apoptosis through Tumor Necrosis Factor α–Mediated Ceramide De novo Synthesis in Colon Cancer Cells

  2008cited by this paper
• Expression and function of fatty acid amide hydrolase in prostate cancer

  2008cited by this paper
• The influence of mast cell mediators on migration of SW756 cervical carcinoma cells.

  2008cited by this paper
• Loss of cannabinoid receptor 1 accelerates intestinal tumor growth.

  2008cited by this paper
• Opposing Actions of Endocannabinoids on Cholangiocarcinoma Growth

  2007cited by this paper
• The multidrug transporter ABCG2 (BCRP) is inhibited by plant‐derived cannabinoids

  2007influential reference
• Diverse roles of 2‐arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12‐lipoxygenase metabolism

  2007cited by this paper

• From Screening to a Nanotechnological Platform: Cannabidiol–Chemotherapy Co-Loaded Lipid Nanocapsules for Glioblastoma Multiforme Treatment

  2025cites this paper
• Bioinformatics differential expression analysis of the effect of cannabidiol in chronic myeloid leukaemia cell line

  2025cites this paper
• Small-molecule photoacoustic probes for in vivo imaging.

  2025cites this paper
• A superexpressão dos receptores canabinoides nas neoplasias malignas de mama e sua repercussão clínica

  2025cites this paper
• The Role of the Endocannabinoid System in Oncology and the Potential Use of Cannabis Derivatives for Cancer Management in Companion Animals

  2025cites this paper
• Molecular Mechanisms of the Endocannabinoid System with a Focus on Reproductive Physiology and the Cannabinoid Impact on Fertility

  2025cites this paper
• Impact of minor cannabinoids on key pharmacological targets of estrogen receptor-positive breast cancer.

  2025cites this paper
• Antiproliferative effects of arvanil, olvanil and LY2183240 on human neuroblastoma and glioblastoma cell lines and their in vitro interactions with cisplatin and temozolomide: an isobolographic analysis.

  2025cites this paper
• Codelivery of Paclitaxel and Cannabidiol in Lipid Nanoparticles Enhances Cytotoxicity against Melanoma Cells

  2025cites this paper
• The endocannabinoid system in cancer biology: a mini-review of mechanisms and therapeutic potential

  2025cites this paper
• Transcriptional Profiling of SSEA‐1+ Endometrial Epithelial Progenitor Cells Highlights Their Role in Endometrial Regeneration, Remodeling, and Homeostasis

  2025cites this paper
• Impact of cannabinoids on cancer outcomes in patients receiving immune checkpoint inhibitor immunotherapy

  2025cites this paper
• Carboxylesterase 1-mediated endocannabinoid metabolism in skin: role in melanoma progression in BRafV600E/Pten−/− mice

  2025cites this paper
• Targeting the Endocannabinoid System Present in the Glioblastoma Tumour Microenvironment as a Potential Anti-Cancer Strategy

  2024cites this paper
• Non-coding RNAs as Key Regulators of the Notch Signaling Pathway in Glioblastoma: Diagnostic, Prognostic, and Therapeutic Targets.

  2024cites this paper
• Drug repurposing opportunities for breast cancer and seven common subtypes.

  2024cites this paper
• Combinatorial effects of cannabinoid receptor 1 and 2 agonists on characteristics and proteomic alteration in MDA-MB-231 breast cancer cells

  2024cites this paper
• Co-delivery of Paclitaxel and Cannabidiol in Lipid Nanoparticles Enhances Cytotoxicity Against Melanoma Cells

  2024cites this paper
• Exploring the Potential of Synthetic Cannabinoids: Modulation of Biological Activity of Normal and Cancerous Human Colon Epithelial Cells

  2024cites this paper
• Molecular Targets of Minor Cannabinoids in Breast Cancer: In Silico and In Vitro Studies

  2024cites this paper
• Ferroptosis-targeting drugs in breast cancer

  2024cites this paper
• Endocannabinoid system and phytocannabinoids in the main species of veterinary interest: a comparative review

  2024cites this paper
• Investigating endocannabinoid system and subjective responses to exercise in cancer patients: Rationale and future research directions

  2024cites this paper
• Fatty Acid Amides Suppress Proliferation via Cannabinoid Receptors and Promote the Apoptosis of C6 Glioma Cells in Association with Akt Signaling Pathway Inhibition

  2024cites this paper
• Preparation and characterization of PBS (Polybutylene Succinate) nanoparticles containing cannabidiol (CBD) for anticancer application

  2024cites this paper
• Anti-Cancer and Anti-Proliferative Potential of Cannabidiol: A Cellular and Molecular Perspective

  2024cites this paper
• Endocannabinoid remodeling in murine cachexic muscle associates with catabolic and metabolic regulation.

  2024cites this paper
• The evolution of cannabinoid receptors in cancer.

  2023cites this paper
• Effect of Docosahexaenoic Acid Encapsulation with Whey Proteins on Rat Growth and Tissue Endocannabinoid Profile

  2023cites this paper
• Tumor microenvironment-derived monoacylglycerol lipase provokes tumor-specific immune responses and lipid profiles.

  2023cites this paper
• CBD as a Physiological Modulator for Cancer

  2023cites this paper
• Pharmacokinetics, efficacy, and safety of cannabidiol in dogs: an update of current knowledge

  2023cites this paper
• Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer

  2023cites this paper
• Cannabidiol as a Promising Adjuvant Therapy for Estrogen Receptor-Positive Breast Tumors: Unveiling Its Benefits with Aromatase Inhibitors

  2023cites this paper
• A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate Cancer

  2023cites this paper
• The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma.

  2023cites this paper
• Cannabinoids And Cannabinoid-Like Compounds: Biochemical Characterization And Pharmacological Perspectives

  2023cites this paper
• Cannabinoid receptor 2 plays a pro-tumorigenic role in non-small cell lung cancer by limiting anti-tumor activity of CD8+ T and NK cells

  2023cites this paper
• Classic Hodgkin Lymphoma Refractory for ABVD Treatment Is Characterized by Pathologically Activated Signal Transduction Pathways as Revealed by Proteomic Profiling

  2022influential citation
• Role of classical cannabinoid receptors in cancer-associated bone disease

  2022cites this paper
• Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics

  2022cites this paper
• Uporaba kanabinoidov v medicinske namene: Ali so pritiski javnosti in laikov utemeljeni?

  2022cites this paper
• Cannabis Biomolecule Effects on Cancer Cells and Cancer Stem Cells: Cytotoxic, Anti-Proliferative, and Anti-Migratory Activities

  2022cites this paper
• Beyond monoamines: I. Novel targets and radiotracers for Positron emission tomography imaging in psychiatric disorders

  2022cites this paper
• Synthetic cannabinoid WIN 55,212–2 inhibits growth and induces cell death of oral and pancreatic stem-like/poorly differentiated tumor cells

  2022cites this paper
• Anti-Cancer Activity of Cannabis sativa Phytocannabinoids: Molecular Mechanisms and Potential in the Fight against Ovarian Cancer and Stem Cells

  2022influential citation
• Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism

  2022cites this paper
• Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities.

  2022cites this paper
• Disorders of cancer metabolism: The therapeutic potential of cannabinoids.

  2022cites this paper
• Cannabinoids in Breast Cancer: Differential Susceptibility According to Subtype

  2021cites this paper
• Transcription Profile and Pathway Analysis of the Endocannabinoid Receptor Inverse Agonist AM630 in the Core and Infiltrative Boundary of Human Glioblastoma Cells

  2021cites this paper
• A Highly Effective Treatment?

  2021cites this paper
• Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival

  2021cites this paper
• Pros and Cons of the Cannabinoid System in Cancer: Focus on Hematological Malignancies

  2021cites this paper
• The Interplay between the Immune and the Endocannabinoid Systems in Cancer

  2021influential citation
• Medical cannabis in pediatric oncology: a survey of patients and caregivers

  2021cites this paper
• Palmitoylethanolamide Reduces Colon Cancer Cell Proliferation and Migration, Influences Tumor Cell Cycle and Exerts In Vivo Chemopreventive Effects

  2021cites this paper
• Molecular Mechanism of Cannabinoids in Cancer Progression

  2021cites this paper
• Anticancer Potential of Small‐Molecule Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase

  2021cites this paper
• Human laryngeal squamous cell carcinoma cell line release of endogenous anandamide and 2-arachidonoylglycerol, and their antiproliferative effect via exogenous supplementation: an in vitro study

  2021cites this paper
• Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER+ breast cancer cells: impact on aromatase and steroid receptors.

  2021cites this paper
• A novel chemical inhibitor suppresses breast cancer cell growth and metastasis through inhibiting HPIP oncoprotein

  2021cites this paper
• The Endocannabinoid System in Caenorhabditis elegans.

  2021cites this paper
• The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases

  2021cites this paper
• Osteosarcoma in Children: Not Only Chemotherapy

  2021cites this paper
• Cannabinoid receptor CB1 and CB2 interacting proteins: Techniques, progress and perspectives.

  2021cites this paper
• Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment

  2021cites this paper
• A fluorescent sensor for spatiotemporally resolved imaging of endocannabinoid dynamics in vivo

  2021cites this paper
• TIBBİ KENEVİR VE SAĞLIK: FARMAKOLOJİK BİR DERLEME

  2021cites this paper
• Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches

  2021cites this paper
• Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice

  2020cites this paper
• The Immune Endocannabinoid System of the Tumor Microenvironment

  2020influential citation
• Targeted Delivery of CBD-Loaded Poly (RGD) Proteinoid Nanoparticles for Antitumor Therapy

  2020cites this paper
• The Highs and Lows of Cannabis in Cancer Treatment and Bone Marrow Transplantation

  2020cites this paper
• Effect of monoacylglycerol lipase inhibition on intestinal permeability in chronic stress model.

  2020cites this paper
• Urine Endocannabinoids as Novel Non-Invasive Biomarkers for Bladder Cancer at Early Stage

  2020cites this paper
• Scoping Review and Meta-Analysis Suggests that Cannabis Use May Reduce Cancer Risk in the United States

  2020cites this paper
• Cannabinoid Receptor Subtype 2 (CB2R) in a Multitarget Approach: Perspective of an Innovative Strategy in Cancer and Neurodegeneration.

  2020cites this paper
• A fluorescent sensor for spatiotemporally resolved endocannabinoid dynamics in vitro and in vivo

  2020cites this paper
• Enhancing ovarian cancer conventional chemotherapy through the combination with cannabidiol loaded microparticles.

  2020cites this paper
• Cannabidiol primer for healthcare professionals

  2020cites this paper
• Cannabis, the Endocannabinoid System and Immunity—the Journey from the Bedside to the Bench and Back

  2020cites this paper
• PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment

  2020cites this paper
• The Endocannabinoid System: A Target for Cancer Treatment

  2020cites this paper
• Cannabis sativa: much more beyond Δ9-tetrahydrocannabinol.

  2020cites this paper
• Cannabinoids in Medicine: Cancer, Immunity, and Microbial Diseases

  2020cites this paper
• (Endo)Cannabinoids and Gynaecological Cancers

  2020cites this paper
• The Role of the Endocannabinoid Signaling System in the Pathophysiology of Asthma and Obesity

  2019cites this paper
• Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice

  2019cites this paper
• Role of cannabinoid receptor 2 in mediating interleukin-1β-induced inflammation in rheumatoid arthritis synovial fibroblasts.

  2019cites this paper
• Expression of Cannabinoid Receptors in Myometrium and its Correlation With Dysmenorrhea in Adenomyosis

  2019cites this paper
• Decreased Expression of Cannabinoid Receptors in the Eutopic and Ectopic Endometrium of Patients with Adenomyosis

  2019cites this paper
• New Prospect for Cancer Cachexia: Medical Cannabinoid

  2019cites this paper
• CBD loaded microparticles as a potential formulation to improve paclitaxel and doxorubicin-based chemotherapy in breast cancer.

  2019cites this paper
• Concomitant Treatment of Malignant Brain Tumours With CBD – A Case Series and Review of the Literature

  2019cites this paper
• Cannabidiol: A budding industry!

  2019cites this paper
• Determination of endocannabinoids and endocannabinoid-like substances in human K3EDTA plasma - LC-MS/MS method validation and pre-analytical characteristics.

  2019cites this paper
• Insights into the effects of the endocannabinoid system in cancer: a review

  2018cites this paper
• Medical Use of Cannabinoids

  2018cites this paper
• Rimonabant Kills Colon Cancer Stem Cells without Inducing Toxicity in Normal Colon Organoids

  2018cites this paper